S23-015 Blocking an immune receptor signal to treat obesity and fatty liver disease Stanford scientists have discovered that blocking an immune receptor signal can lead to increased fat uptake and weight reduction in patients suffering from obesity and associated diseases. Gerlinde Wernig Cristabelle De Souza Qiwen Deng
S19-533 Use of Small Molecule Inhibitor for Preventing Abdominal Adhesions Researchers at Stanford have identified a novel method of use for the drug T-5224 in the prevention of abdominal adhesion. Michael Longaker Gerlinde Wernig Jeffrey Norton Geoffrey Gurtner Michael Januszyk Deshka Foster Malini Chinta
S20-364 New Immunotherapeutic Target for the Treatment of Lung Cancer and Fibrotic Lung Diseases Stanford scientists have discovered a new immunotherapeutic target for treating lung cancer and fibrotic lung disease. Gerlinde Wernig Tristan Lerbs Lu Cui Qiwen Deng Cristabelle De Souza